PineBridge’s Rob Hinchliffe shares where he sees opportunities in the current market.
Tag: Biotech
Central banks catch their breath: Will biotech shine again as rates stop rising?
Rate hikes tend to be bad news for ‘jam tomorrow’ sectors but the cycle is ending.
Can pharma and biotech ease pain in a financial crisis?
Ten years after the global financial crisis of 2008, FSA notes that pharmaceutical, healthcare and biotech stocks weathered that year better than other sectors.
Video: Janus Henderson on healthcare equities
Adam Johnson, senior product specialist, explains the potential pitfalls when investing in the healthcare sector.
